yttrium-90 microspheres (Part II): pre-treatment evaluation and post-treatment follow-up for patients with hepatic malignancy receiving yttrium-90 microspheres embolization

Yttrium-90 (⁹⁰Y) radioembolization therapy can directly deliver a high dose of radiation to the tumor being targeted, which has been demonstrated to be effective in treating patients with hepatic malignancy. Compared with transarterial chemoembolization, ⁹⁰Y radioembolization is less frequently associated with toxicities such as abdominal pain, fever, nausea, and vomiting. However, the efficacy and safety of ⁹⁰Y radioembolization therapy are largely reliant on careful preprocedural evaluation and diligent follow-up. This review discusses the details of essential preprocedural work-up and postprocedural follow-up for patients treated with ⁹⁰Y radioembolization. (authors)